Drug profile · INN
sipavibart
KAVIGALE
sipavibart (KAVIGALE) is an FDA-listed pharmaceutical active ingredient.
EMA: approved PMDA: approved Antiinfectives for systemic use (J06) J06BD09
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — sipavibart
- Class
- Antiinfectives for systemic use (J06)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
sipavibart (KAVIGALE) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN sipavibart
Brand KAVIGALE
Therapeutic class Antiinfectives for systemic use (J06)
ATC code J06BD09
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sipavibart?
sipavibart (KAVIGALE) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for sipavibart?
KAVIGALE is a marketed brand name for sipavibart. Check FDA Drugs@FDA for the current US label holder and prescribing information.